Reprogramming of Ovarian Granulosa Cells by YAP1 Leads to Development of High-Grade Cancer with Mesenchymal Lineage and Serous Features

Xiangmin Lv,Chunbo He,Cong Huang,Guohua Hua,Xingcheng Chen,Barbara K. Timm,Victoria M. Maclin,Abigail A. Haggerty,Shelly K. Aust,Denae M. Golden,Bhavana J. Dave,Yun-An Tseng,Li Chen,Hongbo Wang,Peichao Chen,David L. Klinkebiel,Adam R. Karpf,Jixin Dong,Ronny I. Drapkin,Bo R. Rueda,John S. Davis,Cheng Wang
DOI: https://doi.org/10.1016/j.scib.2020.03.040
IF: 18.9
2020-01-01
Science Bulletin
Abstract:Understanding the cell-of-origin of ovarian high grade serous cancer (HGSC) is the prerequisite for efficient prevention and early diagnosis of this most lethal gynecological cancer. Recently, a mesenchymal type of ovarian HGSC with the poorest prognosis among ovarian cancers was identified by both TCGA and AOCS studies. The cell-of-origin of this subtype of ovarian cancer is unknown. While pursuing studies to understand the role of the Hippo pathway in ovarian granulosa cell physiology and pathology, we unexpectedly found that the Yes-associated protein 1 (YAP1), the major effector of the Hippo signaling pathway, induced dedifferentiation and reprogramming of the ovarian granulosa cells, a unique type of ovarian follicular cells with mesenchymal lineage and high plasticity, leading to the development of high grade ovarian cancer with serous features. Our research results unveil a potential cell-of-origin for a subtype of HGSC with mesenchymal features.
What problem does this paper attempt to address?